---
accession : E-GEOD-16452
platform  : A-AFFY-44
pathway   : JAK-STAT
cells     : human BE(2)-C neuroblastoma cells
treatment : IFN-alpha
effect    : activating
hours     : 6

control   :
    - GSE16452GSM413549
    - GSE16452GSM413550
    - GSE16452GSM413551
perturbed :
    - GSE16452GSM413552
    - GSE16452GSM413553
    - GSE16452GSM413554

---
accession : E-GEOD-16452
platform  : A-AFFY-44
pathway   : JAK-STAT
cells     : human BE(2)-C neuroblastoma cells
treatment : IFN-alpha
effect    : activating
hours     : 12

control   :
    - GSE16452GSM413549
    - GSE16452GSM413550
    - GSE16452GSM413551
perturbed :
    - GSE16452GSM413555
    - GSE16452GSM413556
    - GSE16452GSM413557

---
accession : E-GEOD-16452
platform  : A-AFFY-44
pathway   : JAK-STAT
cells     : human BE(2)-C neuroblastoma cells, retinoic acid differentiation
treatment : IFN-alpha
effect    : activating
hours     : 6

control   :
    - GSE16452GSM413558
    - GSE16452GSM413559
    - GSE16452GSM413560
perturbed :
    - GSE16452GSM413561
    - GSE16452GSM413562
    - GSE16452GSM413563

---
accession : E-GEOD-16452
platform  : A-AFFY-44
pathway   : JAK-STAT
cells     : human BE(2)-C neuroblastoma cells, retinoic acid differentiation
treatment : IFN-alpha
effect    : activating
hours     : 12

control   :
    - GSE16452GSM413558
    - GSE16452GSM413559
    - GSE16452GSM413560
perturbed :
    - GSE16452GSM413564
    - GSE16452GSM413565
    - GSE16452GSM413566
...
